Back to Directory

Apeikon Therapeutics

Founded 2020
Image-guided nanoparticles for targeted cancer drug delivery

Apeikon Therapeutics is a biotechnology company developing image-guided drug delivery systems for cancer treatment. Its platform uses drug-filled nanoparticles and magnetic resonance-guided focused ultrasound to concentrate treatment within tumours while aiming to reduce systemic toxicity. The technology is designed to carry existing or experimental anticancer agents, including combinations of drugs, and has been evaluated in preclinical cancer models.